-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

Dow Jones·02/21/2024 18:54:00

Please log in to view news